Numira Biosciences acquires Ricerca's Bothell lab operations

Related tags Life Medicine

US-based Numira Biosciences has expanded its imaging and pre-clinical services portfolio after acquiring the efficacy pharmacology operating unit of Ricerca Biosciences.

Numira, which specialises in high resolution 3D imaging and visualisation software for the life science market, claim the Washington state site, located in Bothell, providesh a “state-of-the-art, GLP compliant facility, with a highly talented team and a broad range of laboratory capabilities.”

Michael Beeuwsaert, CEO of Numira said: “The Bothell site has a long-standing, strong reputation in the CRO market and possesses deep scientific expertise in several therapeutic areas that compliment Numira's imaging technology.

By combining our respective strengths, we are well positioned to provide even greater value to both Numira's and Ricerca's clients and pursue new opportunities for growth.”

Related news

Related products

Small Molecule development – getting it right

Small Molecule development – getting it right

Content provided by Lonza Small Molecules | 20-Jun-2023 | Insight Guide

Small Molecule drug development is something more and more ambitious emerging pharmaceutical companies are taking on from end to end. But this path can...

How Sponsors Reduce Chaos in Decentralized Trials

How Sponsors Reduce Chaos in Decentralized Trials

Content provided by Florence Healthcare | 08-Mar-2023 | Insight Guide

89% of research sponsors currently use and expect to continue the use of decentralized technologies and methods, according to our state of the industry...

Related suppliers

Follow us


View more